Poland· PL-100311790
Methylthioninium chloride Proveblue
A methylthioninium chloride product containing methylthioninii chloridum, registered in Poland by Provepharm SAS. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Methylthioninium chloride is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AB17 (methylthioninium chloride), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Methylthioninium chloride · ATC V03AB17
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Methylthioninii chloridum
- Manufacturer
- Provepharm SAS
- Country
- Poland (PL)
- ATC code
- V03AB17
- ATC class
- Methylthioninium chloride
- Defined daily dose
- 0.105 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin03760237160096
- gtin03760237160102
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
213 interactions on record for methylthioninium chloride.
Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylthioninium chloride · interactions on record
213 records
- 141 severe
- 71 moderate
- 1 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methylthioninium chloride in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ecd1b209-4409-41b8-b1e0-b30d0c1fb35c GET /v1/drugs/ecd1b209-4409-41b8-b1e0-b30d0c1fb35c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "5 mg/ml",
"packaging": "03760237160096 ¦ Rpz ¦ EU/1/11/682/001 ¦ 89770\n5 amp. 10 ml\n03760237160102 ¦ Rpz ¦ EU/1/11/682/002 ¦ 89771\n5 amp. 2 ml\nRpz ¦ EU/1/11/682/003 ¦ 89772\n20 amp. 2 ml",
"substance": "Methylthioninii chloridum 5 mg/ml",
"common_name": "Methylthioninii chloridum",
"pl_product_id": "100311790",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about methylthioninium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.